Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | SPRY2 |
| Upstream (Parents) |
|---|
| (<<) AQP3 → SPRY2 |
| (<<) CASP4 → SPRY2 |
| (<<) CAV1 → SPRY2 |
| (<<) CYP1B1 → SPRY2 |
| (<<) DUSP6 → SPRY2 |
| (<<) DUSP7 → SPRY2 |
| (<<) EFEMP1 → SPRY2 |
| (<<) EGFR → SPRY2 |
| (<<) GNA11 → SPRY2 |
| (<<) GPNMB → SPRY2 |
| (<<) LYPD5 → SPRY2 |
| (<<) MAP1B → SPRY2 |
| (<<) MAPKAPK5 → SPRY2 |
| (<<) PTGS1 → SPRY2 |
| (<<) RASD1 → SPRY2 |
| (<<) SH2D2A → SPRY2 |
| (<<) SOD3 → SPRY2 |
| Downstream (Children) |
|---|
| SPRY2 → ATP10B (>>) |
| SPRY2 → DOCK9 (>>) |
| SPRY2 → ETS2 (>>) |
| SPRY2 → GRB2 (>>) |
| SPRY2 → HOXA3 (>>) |
| SPRY2 → ITGA6 (>>) |
| SPRY2 → ORM1 (>>) |
| SPRY2 → RASA1 (>>) |
| SPRY2 → SGK1 (>>) |
| SPRY2 → TNC (>>) |
